VictoriaElizabethWangMD

PubMed

• Phase II Study of Erdafitinib in Patients With Tumors With Fibroblast Growth Factor Receptor Mutations or Fusions: Results From the NCI-MATCH ECOG-ACRIN Trial (EAY131)...
  Jun Gong, Alain C Mita, Zihan Wei, Heather H Cheng, Edith P Mitchell, John J Wright, S Percy Ivy, Victoria Wang, Robert C Gray, Lisa M McShane, Larry V Rubinstein, Dav...> ;JCO Precision Oncology. 2024 Apr 1
• Phase II Study of Erdafitinib in Patients With Tumors WithAmplifications: Results From the NCI-MATCH ECOG-ACRIN Trial (EAY131) Subprotocol K1.
  Jun Gong, Alain C Mita, Zihan Wei, Heather H Cheng, Edith P Mitchell, John J Wright, S Percy Ivy, Victoria Wang, Robert C Gray, Lisa M McShane, Larry V Rubinstein, Dav...> ;JCO Precision Oncology. 2024 Apr 1
• Phase II Study of Osimertinib in Patients With Epidermal Growth Factor Receptor Mutations: Results From the NCI-MATCH ECOG-ACRIN (EAY131) Trial Subprotocol E.
  Monica F Chen, Zihe Song, Helena A Yu, Lecia V Sequist, Christine M Lovly, Edith P Mitchell, Jeffrey A Moscow, Robert J Gray, Victoria Wang, Lisa M McShane, Larry V Ru...> ;JCO Precision Oncology. 2024 Apr 1
• Trastuzumab and Pertuzumab in Patients with Non-Breast/Gastroesophageal HER2-Amplified Tumors: Results from the NCI-MATCH ECOG-ACRIN Trial (EAY131) Subprotocol J.
  Roisin M Connolly, Victoria Wang, David M Hyman, Petros Grivas, Edith P Mitchell, John J Wright, Elad Sharon, Robert J Gray, Lisa M McShane, Larry V Rubinstein, David ...> ;Clinical Cancer Research. 2024 Apr 1
• 3 citations
  Ibrutinib-based therapy reinvigorates CD8+ T cells compared to chemoimmunotherapy: immune monitoring from the E1912 trial.
  Despoina Papazoglou, Tait D Shanafelt, Nikolaos Ioannou, Giulia De Rossi, Sylvia Herter, Marina Bacac, Christian Klein, Martin S Tallman, Neil E Kay, Alan G Ramsay, Xi...> ;Blood. 2024 Jan 4
• IGF-1 axis changes with ADT and docetaxel in metastatic prostate cancer.
  Praful Ravi, Victoria Wang, Raina N Fichorova, Bradley McGregor, Xiao X Wei, Shehzad Basaria, Christopher J Sweeney> ;Endocrine-Related Cancer. 2023 Nov 1
• 13 citations
  The NCI-MATCH trial: lessons for precision oncology.
  Peter J O'Dwyer, Robert J Gray, Keith T Flaherty, Alice P Chen, Shuli Li, Victoria Wang, Lisa M McShane, David R Patton, James V Tricoli, P Mickey Williams, A John Iaf...> ;Nature Medicine. 2023 Jun 1
• Hypoxia-specific imaging in patients with lymphoma undergoing CAR-T therapy.
  Rahul Banerjee, Victoria Wang, Chiung-Yu Huang, Divita Pandita, Michelle K Leonard, Siobhan LaRue, Michael Ahmadi, Lawrence Kaplan, Weiyun Z Ai, Bita Fakhri, Michael S...> ;European Journal of Nuclear Medicine and Molecular Imaging. 2023 Sep 1
• 3 citations
  Phase II Study of Palbociclib (PD-0332991) in CCND1, 2, or 3 Amplification: Results from the NCI-MATCH ECOG-ACRIN Trial (EAY131) Subprotocol Z1B.
  Clark, A., Hong, F., Finn, R., DeMichele, A., Mitchell, E., Zwiebel, J., Arnaldez, F., Gray, R., Wang, V., McShane, L., Rubinstein, L., Patton, D., Williams, P., Hamil...> ;Clinical Cancer Research. 2023 Apr 14
• 1 citations
  Fear of recurrence, emotional well-being and quality of life among long-term advanced ovarian cancer survivors.
  Kathryn Osann, Lari Wenzel, Chelsea McKinney, Lynne Wagner, David Cella, Giulia Fulci, Mary J Scroggins, Heather A Lankes, Victoria Wang, Kenneth P Nephew, George L Ma...> ;Gynecologic Oncology. 2023 Apr 1
• 14 citations
  Genetic determinants of chromatin reveal prostate cancer risk mediated by context-dependent gene regulation.
  Sylvan C Baca, Cassandra Singler, Soumya Zacharia, Ji-Heui Seo, Tunc Morova, Faraz Hach, Yi Ding, Tommer Schwarz, Chia-Chi Flora Huang, Jacob Anderson, André P Fay, Cy...> ;Nature Genetics. 2022 Sep 1
• 6 citations
  Phase II Study of Afatinib in Patients With Tumors With Human Epidermal Growth Factor Receptor 2-Activating Mutations: Results From the National Cancer Institute-Molec...
  Philippe L Bedard, Shuli Li, Kari B Wisinski, Eddy S Yang, Sewanti A Limaye, Edith P Mitchell, James A Zwiebel, Jeffrey A Moscow, Robert J Gray, Victoria Wang, Lisa M ...> ;JCO Precision Oncology. 2022 Jul 1
• 23 citations
  Phase II Study of Copanlisib in Patients With Tumors WithMutations: Results From the NCI-MATCH ECOG-ACRIN Trial (EAY131) Subprotocol Z1F.
  Senthil Damodaran, Fengmin Zhao, Dustin A Deming, Edith P Mitchell, John J Wright, Robert J Gray, Victoria Wang, Lisa M McShane, Larry V Rubinstein, David R Patton, P ...> ;Journal of Clinical Oncology. 2022 May 10
• 11 citations
  Phase II Study of Taselisib in-Mutated Solid Tumors Other Than Breast and Squamous Lung Cancer: Results From the NCI-MATCH ECOG-ACRIN Trial (EAY131) Subprotocol I.
  Ian E Krop, Opeyemi A Jegede, Juneko E Grilley-Olson, Josh D Lauring, Edith P Mitchell, James A Zwiebel, Robert J Gray, Victoria Wang, Lisa M McShane, Larry V Rubinste...> ;JCO Precision Oncology. 2022 Feb 1
• 1 citations
  Inference in response-adaptive clinical trials when the enrolled population varies over time.
  Massimiliano Russo, Steffen Ventz, Victoria Wang, Lorenzo Trippa> ;Biometrics. 2021 Nov 10
• 8 citations
  Quality of Life and Adverse Events: Prognostic Relationships in Long-Term Ovarian Cancer Survival.
  Lari Wenzel, Kathryn Osann, Chelsea O. McKinney, David Cella, Giulia Fulci, Mary J Scroggins, Heather A. Lankes, Victoria Wang, Kenneth P. Nephew, George L. Maxwell, S...> ;Journal of the National Cancer Institute. 2021 Oct 1
• 46 citations
  Molecular classification improves risk assessment in adult BCR-ABL1-negative B-ALL.
  Elisabeth Paietta, Kathryn G. Roberts, Victoria Wang, Zhaohui Gu, Georgina Buck, Deqing Pei, Cheng Cheng, Ross L. Levine, Omar Abdel-Wahab, Zhongshan Cheng, Gang Wu, C...> ;Blood. 2021 Sep 16
• 3 citations
  Inhibition of MET Signaling with Ficlatuzumab in Combination with Chemotherapy in Refractory AML: Clinical Outcomes and High-Dimensional Analysis
  Victoria E. Wang, Bradley W. Blaser, Ravi K. Patel, Gregory K. Behbehani, Arjun A. Rao, Blythe Durbin-Johnson, Tommy Jiang, Aaron C Logan, Matthew L. Settles, Gabriel ...> ;Blood Cancer Discovery. 2021 Jul 16
• 4 citations
  A polymorphism in the promoter of FRAS1 is a candidate SNP associated with metastatic prostate cancer.
  Victoria Wang, Milan S. Geybels, Kristina M. Jordahl, Travis Gerke, Anis A. Hamid, Kathryn L. Penney, Sarah C. Markt, Matthew L. Freedman, Mark Pomerantz, Gwo-Shu Mary...> ;The Prostate. 2021 Jul 1
• 51 citations
  Enhancer Hijacking Drives Oncogenic BCL11B Expression in Lineage-Ambiguous Stem Cell Leukemia.
  Lindsey E. Montefiori, Sonja Bendig, Zhaohui Gu, Xiao-Long Chen, Petri Pölönen, Xiaotu Ma, Alex Murison, Andy G.X. Zeng, Laura García-Prat, Kirsten Dickerson, Ilaria I...> ;Cancer Discovery. 2021 Jun 8
• 19 citations
  Differential Outcomes in Codon 12/13 and Codon 61 NRAS-Mutated Cancers in the Phase II NCI-MATCH Trial of Binimetinib in Patients with NRAS-Mutated Tumors.
  James M. Cleary, Victoria Wang, Rebecca S. Heist, E. Scott Kopetz, Edith P. Mitchell, James A. Zwiebel, Kevin S. Kapner, Helen X. Chen, Shuli Li, Robert Gray, Lisa M. ...> ;Clinical Cancer Research. 2021 Jun 1
• 3 citations
  Evaluation of a National Comprehensive Cancer Network Guidelines-Based Decision Support Tool in Patients With Non-Small Cell Lung Cancer: A Nonrandomized Clinical Trial
  Susan Y. Wu, Ann A. Lazar, Matthew A. Gubens, Collin M. Blakely, Alexander Gottschalk, David M. Jablons, Thierry Jahan, Victoria E. Wang, Taylor L Dunbar, Melisa L. Wo...> ;JAMA Network Open. 2020 Sep 1
• 179 citations
  Aurora kinase A drives the evolution of resistance to third-generation EGFR inhibitors in lung cancer.
  Khyati N. Shah, Roma Bhatt, Julia K Rotow, Julia Rohrberg, Victor Olivas, Victoria E. Wang, Golzar Hemmati, Maria M. Martins, Ashley Maynard, Jonathan Kuhn, Jacqueline...> ;Nature Medicine. 2019 Jan 1
• 24 citations
  Aberrant GSK3β nuclear localization promotes AML growth and drug resistance
  James J. Ignatz-Hoover, Victoria Wang, Nathan Mackowski, Anne Roe, Isaac K. Ghansah, Masumi Ueda, Hillard M. Lazarus, Marcos de Lima, Elisabeth Paietta, Hugo F. Fernan...> ;Blood Advances. 2018 Nov 13
• 5 citations
  CD74-ROS1 Fusion in NSCLC Detected by Hybrid Capture-Based Tissue Genomic Profiling and ctDNA Assays.
  Victoria E. Wang, Trever G. Bivona, Siraj M. Ali, Alexa B. Schrock, Vincent A. Miller> ;Journal of Thoracic Oncology. 2017 Feb 1
• Join now to see all